The successor, Oncology Care First, will likely include two tracks with downside risk right from the start.
Jennifer Gershman, PharmD, CPh
The new and proposed federal regulations, as well as state laws, that are trending across the United States.
Here are the top drugs expected to be approved this year and their financial impact.
A program that balances scientific advances and cost, oncology clinical pathways can be an important tool for improving quality of care.
Pain management drugs in phase 3 development show promise as abuse-deterrent formulations of opioid therapies.
Phase 3 drugs show innovative approaches to cancer treatment.
MS is in need of new medications—these could be the future.